A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

Summary

This study will evaluate the percentage change in body weight from baseline and proportion of subjects achieving ≥ 5% weight loss from baseline after 52 weeks of treatment with Zovaglutide in subjects with overweight/obesity.

Timeline

Start

2026-03-08

Primary completion

2027-05-29

Completion

2027-06-26

Drugs

Indications